Breakthrough improves chances tissue grafts will survive, thrive
April 11, 2016
A better understanding of the effect of mechanical forces on blood vessel assembly in engineered tissues aids optimal growth of new blood vessels after tissue transplantation
Researchers from the Technion-Israel Institute of Technology and colleagues in the U.S. have developed technology to tailor grafted tissues that can respond to certain natural forces affecting blood vessels. The researchers also found that matching the structure of the engineered vessels to the structure of the host tissues at the site of implantation helps the tissue implant integration, improving the chances that grafted tissues will survive. The findings were published recently in The Proceedings of the National Academy of Sciences (PNAS).
“Developing functional and mature three-dimensional (3D) blood vessel networks in implantable tissues is critical when using these engineered tissues to treat a number of conditions, such as cardiovascular disease and trauma injuries,” said lead researcher Prof. Shulamit Levenberg of the Technion Department of Biomedical Engineering. “Matching the tissue structures will improve the long term viability and strength of tissue grafts when new blood vessel growth – called ‘angiogenesis’ – can be manipulated and exploited for the purpose of attaining optimal blood supply.”
The team’s laboratory studies were aimed at determining just how vascular networks are regulated by various kinds of “tensile forces”- by stretching the constructs (3D engineered tissues).
“Although mechanical forces play a central role in all biological processes as well as influence the shape and organization of cells, mechanical forces had not been previously investigated in relation to vascular networks in 3D,” explained Prof. Levenberg. “Our study used a number of techniques to monitor the impact of tensile forces on vascular network construction and properties.”
The researchers examined the effects of cell-induced forces on vascular networks by applying variety of stretching forces, both cyclic (on-and-off) and static (constant) forces. The researchers found that the vessels aligned in response to the stretch.
To test the effects of vessel alignments on tissue integration, the researchers grafted engineered tissues into mouse abdominal muscles with the vessel direction placed both parallel and vertically to the natural mouse muscle fibers (host tissues). They found that tissues with vertically implanted blood vessels had greater stiffness and strength when they corresponded to the vertical direction of the host tissue fibers.
This study was conducted in collaboration with Professor Dave Mooney, of Harvard University, who hosted Prof. Levenberg during her sabbatical year. The project was carried out by Dr. Dekel Dado-Rosenfeld as part of her PhD thesis, under the mentorship of Prof. Levenberg. Dr. Dado-Rosenfeld is currently a postdoc at the Massachusetts Institute of Technology, under the auspices of the MIT-Technion Post-Doctoral Fellowship.
The Technion-Israel Institute of Technology is a major source of the innovation and brainpower that drives the Israeli economy, and a key to Israel’s renown as the world’s “Start-Up Nation.” Its three Nobel Prize winners exemplify academic excellence. Technion people, ideas and inventions make immeasurable contributions to the world including life-saving medicine, sustainable energy, computer science, water conservation and nanotechnology. The Joan and Irwin Jacobs Technion-Cornell Institute is a vital component of Cornell Tech, and a model for graduate applied science education that is expected to transform New York City’s economy.
American Technion Society (ATS) donors provide critical support for the Technion—more than $2 billion since its inception in 1940. Based in New York City, the ATS and its network of supporters across the U.S. provide funds for scholarships, fellowships, faculty recruitment and chairs, research, buildings, laboratories, classrooms and dormitories, and more.